Latanoprost Eg

Latanoprost, the active ingredient in Latanoprost Eg, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intraocular pressure and is indicated for the treatment of open‑angle glaucoma and ocular hypertension in adults. GNH USA supplies Latanoprost Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to manage conditions that involve elevated intraocular pressure. - Open-angle glaucoma: reduces intraocular pressure to slow disease progression. - Ocular hypertension: lowers pressure to prevent conversion to glaucoma. - Pseudoexfoliative glaucoma: decreases intraocular pressure to control optic nerve damage.

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eyelash changes: increased length, thickness, or darkness. - Iris pigmentation: gradual darkening of the iris. - Eye irritation: itching or burning sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea affecting clarity. - Cystoid macular edema: fluid accumulation in the macula. - Vision loss: sudden decrease in visual acuity. - Persistent ocular pain: requires immediate evaluation.

Before initiating Latanoprost therapy, consider the following safety measures. - Monitor intraocular pressure: assess response after starting treatment. - Assess for ocular infection: avoid use if active conjunctivitis or keratitis is present. - Evaluate allergy history: discontinue if hypersensitivity develops. - Use with caution in patients with cystoid macular edema: monitor retinal status. - Avoid contact lens wear during treatment: lenses may trap the solution and cause irritation. - Store at room temperature: keep the bottle tightly closed, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analogs: may increase risk of ocular inflammation. - Use with ocular anesthetic drops containing preservatives: can reduce drug absorption.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intraocular pressure‑lowering effect may lead to hypotony. - Carbonic anhydrase inhibitor eye drops: combined therapy may enhance pressure reduction. - Systemic prostaglandin analogs: may increase systemic side‑effect profile. - Anticholinergic eye drops: potential for reduced efficacy of Latanoprost.